10 June 2024 in Journal of the American Society of Nephrology
Key Points: METTL3 was upregulated in CKD, leading to increased m 6 A modification levels. M 6 A modifications were enriched in genes related to the cyclic guanosine monophosphate–AMP synthase-stimulator of IFN genes pathway in CKD. Normalizing heightened METTL3 and m 6 A modification levels showed promise as a strategy to combat kidney disease. Background: Chemical modifications on RNA profoundly affect RNA function and regulation. m 6 A, the most abundant RNA modification in eukaryotes, plays a pivotal role in diverse cellular processes and disease mechanisms. However, its importance is understudied in human CKD samples regarding its influence on pathological mechanisms. Methods: Liquid chromatography–tandem mass spectrometry and methylated RNA immunoprecipitation sequencing were used to examine alterations in m 6 A levels and patterns in CKD samples. Overexpression of the m 6 A writer METTL3 in cultured kidney tubular cells was performed to confirm the effect of m 6 A in tubular cells and explore the biological functions of m 6 A modification on target genes. In addition, tubule-specific deletion of Mettl3 (Ksp-Cre Mettl3 f/f ) mice and antisense oligonucleotides inhibiting Mettl3 expression were used to reduce m 6 A modification in an animal kidney disease model. Results: By examining 127 human CKD samples, we observed a significant increase in m 6 A modification and METTL3 expression in diseased kidneys. Epitranscriptomic analysis unveiled an enrichment of m 6 A modifications in transcripts associated with the activation of inflammatory signaling pathways, particularly the cyclic guanosine monophosphate–AMP synthase (cGAS)-stimulator of IFN genes (STING) pathway. m 6 A hypermethylation increased mRNA stability in cGAS and STING1 as well as elevated the expression of key proteins within the cGAS-STING pathway. Both the tubule-specific deletion of Mettl3 and the use of antisense oligonucleotides to inhibit Mettl3 expression protected mice from inflammation, reduced cytokine expression, decreased immune cell recruitment, and attenuated kidney fibrosis. Conclusions: Our research revealed heightened METTL3-mediated m 6 A modification in fibrotic kidneys, particularly enriching the cGAS-STING pathway. This hypermethylation increased mRNA stability for cGAS and STING1, leading to sterile inflammation and fibrosis.